Sydney Neuroimaging Analysis Centre, an integrated neuroimaging research and commercial medical image analysis facility within the University of Sydney’s Brain and Mind Centre, has secured government grant funding to market its AI-powered software for analysing and monitoring brain diseases.
It also announced on 5 July that it obtained the Therapeutic Goods Administration's clearance for its...
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.
Hikma Pharmaceuticals' venture capital arm, Hikma Ventures, participated in the round alongside Novartis (dRx Capital) and Intermountain Ventures. Existing investors Echo Health Ventures, Deerfield...
Healthcare providers use continuous MRI scans performed over the course of a patient's life to monitor the progression of multiple sclerosis, where the immune system attacks the protective myelin around the nerves within the central nervous system.
MRIs are used to identify lesions or areas of scarring (sclerosis) within the central nervous system. The scarring is the result of the damage caused...
Digital therapeutic maker Happify Health is partnering with neuroscience-focused pharma company Biogen on a digital engagement and education platform for multiple sclerosis.
The product will include Happify's community for people living with MS, as well as access to neurology providers like doctors and nurses, mental health professionals, dietitians and rehabilitation professionals. Biogen will...
It’s no secret that real-world data is becoming a hot topic in the sphere of clinical trials and healthcare. A new study published by JMIR found that patients with multiple sclerosis were able to capture their symptoms via a tracking app called elevateMS. Researchers also found that engagement was highest among those who had a doctor’s referral.
“The elevateMS study app captured the real-world...
This morning patient social network MyHealthTeams revealed exclusively to MobiHealthNews that it is teaming up with EMD Serono to launch a new information resource for patients with multiple sclerosis (MS) who are pregnant or potentially becoming pregnant.
The new tool, called Family Planning Resource Center, will be available within MyMS team, which is part of MyHealthTeam’s social network...
Sanofi has been active in the digital space this week inking two big deals: one with tech company Abbott and the other with digital platform Happify.
The first partnership with Abbott will combine the medtech company’s FreeStyle Libre, a continuous glucose monitoring system, and the pharma giant’s insulin dosing information to create smart pens and insulin titration apps.
Sanofi is currently...
Wearable sensor maker MC10 is teaming up with biopharma company AbbVie on a new set of multiple sclerosis (MS) clinical trials. The pair plan to use MC10’s FDA cleared wearable sensor technology, dubbed the BioStamp nPoint system, to help keep track of a patient’s physiological data and outcomes during the trials.
The flexible and stretchable electronic sensors landed FDA clearance last year to...
Editor's Note: An original headline for this story contained an error, and has since been corrected.
Boston- and San Francisco-based Pear Therapeutics, maker of prescription digital therapeutics for substance abuse, has kicked off a feasibility study for Pear-006, an in-development treatment for depressive symptoms in those with multiple sclerosis (MS).
Pear Therapeutics has been developing Pear-...
Biogen has just launched a new app, called Aby, aimed at giving people living with multiple sclerosis (MS) accurate and reliable information about the condition and support.
The app is free and gives users articles, tips and inspirations about living with the condition. It also provides patients a personal journal, where they can create custom treatment reminders, track appointments, and record...
